Quizartinib
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 400 publications
Atypical Bullous Sweet Syndrome.
Journal: Rhode Island medical journal (2013)
Published: September 25, 2026
Successful Salvage Therapy With Quizartinib Plus Chemotherapy Followed by Quizartinib Monotherapy for Transplant Bridging and Post-Transplant Maintenance in a Child With Induction-Refractory FLT3-ITD-Positive AML.
Journal: Pediatric blood & cancer
Published: August 31, 2026
Strategies to prevent post-transplant relapse in acute myeloid leukemia and myelodysplastic syndromes.
Journal: International journal of hematology
Published: July 29, 2026
Health care resource utilization and costs in patients with acute myeloid leukemia treated with posttransplant maintenance therapy.
Journal: Journal of managed care & specialty pharmacy
Published: July 27, 2026
Phlegmonous Gastritis During Consolidation Therapy With High-Dose Cytarabine and FLT3 Inhibitor in FLT3-ITD-Mutated Acute Myeloid Leukemia.
Journal: Cureus
Published: July 22, 2026
QuANTUM-Wild: a Phase III, randomized trial of quizartinib in newly diagnosed FLT3-ITD-negative acute myeloid leukemia.
Journal: Future oncology (London, England)
Published: July 11, 2026
Design, Synthesis, and Evaluation of Benzimidazole-Based HDAC Inhibitors: Synergistic Effect with FLT3 Inhibitor against AML via Modulation of Tumor Metabolism.
Journal: Journal of medicinal chemistry
Published: June 18, 2026
Recent advances in the treatment of FLT3-mutated acute myeloid leukemia.
Journal: Blood research
Published: June 07, 2026
Last Updated: 11/08/2026